BioCentury
ARTICLE | Company News

Biogen names Karp to lead corporate development

May 31, 2018 4:37 PM UTC

Biogen Inc. (NASDAQ:BIIB) named Daniel Karp EVP of corporate development, effective June 11. The company said he will lead corporate and business development and corporate strategy.

Karp was VP of worldwide business development and head of business development for R&D at Pfizer Inc. (NYSE:PFE)...

BCIQ Company Profiles

Biogen Inc.